The Australian stillbirth rate has remained unchanged for 20 year. Current approaches to identify fetuses at risk of stillbirth is unsuccessful. Women who had stillborn commonly reported on abnormal baby movements prior to the loss. Unfortunately, there are no robust way to assess fetal movements. This project aims to develop a low-cost, lightweight, soft, conformal and non-intrusive wearable fetal movement monitor AI system to understand and reduce stillbirth nationally and globally.
Prediction Of Clinical Outcomes In COPD From Home Monitoring Of Lung Function Variability
Funder
National Health and Medical Research Council
Funding Amount
$513,102.00
Summary
Chronic obstructive pulmonary disease affects close to 30% of the elderly and is the fourth leading cause of male deaths in Australia. There are currently no objective ways to assess disease status and predict future risk of deterioration. We aim to apply novel, sophisticated analysis methods to data from daily home telemonitoring, in order to describe the variability of disease over time and predict risk of exacerbations and quality of life.
Serial NT-proBNP Monitoring For Predicting Major Cardiovascular Events In The Dialysis Population
Funder
National Health and Medical Research Council
Funding Amount
$288,548.00
Summary
Dialysis patients have a 50-100 fold increased risk of dying from heart disease caused by abnormal heart muscle structure and function. Current tests are unable to accurately identify patients at the highest risk. A test that accurately detects the early stages of heart injury is urgently needed. The aim of our research is to develop a monitoring guide using regular testing of a heart hormone (NT-proBNP) to identify high-risk dialysis patients early allowing treatment before a serious medical co ....Dialysis patients have a 50-100 fold increased risk of dying from heart disease caused by abnormal heart muscle structure and function. Current tests are unable to accurately identify patients at the highest risk. A test that accurately detects the early stages of heart injury is urgently needed. The aim of our research is to develop a monitoring guide using regular testing of a heart hormone (NT-proBNP) to identify high-risk dialysis patients early allowing treatment before a serious medical complication occurs.Read moreRead less